News & Reports
Pittsburgh Life Sciences Alliance (PLSA) is dedicated to connecting the companies and people driving the region to become a global leader in human health innovation.
In the News
Viewpoint: Innovation fund aims to make Pennsylvania a powerhouse
"State leaders are showing they get it: If we want a thriving economy, we need to build it."
Gov. Shapiro makes pitch for $50 million for life sciences and other similar areas of research
State's top elected official joined by other local public and private sector leaders in old Ford Assembly plant building, now a research hub.
Pittsburgh biotech firms benefit in potential pharma tariffs and domestic manufacturing shift
Pittsburgh life sciences leaders weigh in on the challenges and opportunities presented by evolving trade policies and uncertain National Institutes of Health funding.
House Majority Policy Committee Examines Life Sciences Economic Impact in Pennsylvania
The House Majority Policy Committee convened in New Kensington to highlight the critical role life sciences play in driving Pennsylvania’s economy.
​The TEConomy Partners, LLC report, released October 2024, outlines a clear path forward for Pittsburgh’s life sciences future. Read more about these tremendous opportunities for the region.
Our Region’s Business: PLSA and Cytoagents:
Originally aired in July 2024, our president and CEO Megan Shaw and Cytoagents CEO, Teresa Whalen, sat down with Bill Flanagan to discuss what southwestern PA needs to turn our region’s life sciences strengths into a global cluster and economic engine.
Abridge, a Lawrenceville startup using generative AI to document and organize doctors notes, is a fantastic example of the innovative companies being built on Pittsburgh’s unique strengths – in this case, bridging healthcare and AI together for real results.
Reports

Independent third-party experts and researchers TEConomy Partners, LLC highlight why the Pittsburgh region is strategically positioned and ready to emerge as a global leader in two key areas of the life sciences industry:
​
1) Data-Driven Healthcare & Connected Devices and
​
2) Next-Gen Therapeutics Development & Manufacturing.